Olivier Loeillot

Olivier Loeillot

President presso REPLIGEN CORPORATION

Patrimonio netto: 3 M $ in data 31/03/2024

54 anni
Health Technology
Finance
Commercial Services

Profilo

Olivier Dominique Loeillot is currently the Director at Puridify Ltd.
and the President & Chief Commercial Officer at Repligen Corp.
He was previously the Chief Executive Officer at Ascensus Specialties LLC, Director at Cytiva Bioscience Holding Ltd., Management Partner at New Mountain Capital LLC, VP Sales LONZA at Lonza AG, and Senior Vice President Bioprocess Division at GE Healthcare CTH Holding Ltd.
He also worked as a Sales Director at Rhodia Pharma Solutions Ltd.
Mr. Loeillot holds an MBA from Emlyon Business School.

Partecipazioni note in società pubbliche

SocietàDataNumero di azioniValorizzazioneData di valutazione
27/02/2024 15 786 ( 0.03% ) 3 M $ 31/03/2024

Posizioni attive di Olivier Loeillot

SocietàPosizioneInizio
REPLIGEN CORPORATION President 02/10/2023
Director/Board Member 24/11/2017
Tutte le posizioni attive di Olivier Loeillot

Precedenti posizioni note di Olivier Loeillot

SocietàPosizioneFine
Chief Executive Officer 01/06/2023
Director/Board Member 01/09/2022
Corporate Officer/Principal 01/04/2020
Sales & Marketing 01/09/2010
Private Equity Investor 01/06/2003
Vedi nel dettaglio l'esperienza di Olivier Loeillot

Formazione di Olivier Loeillot

Emlyon Business School Masters Business Admin

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Olivier Loeillot

Relazioni

28

Relazioni di 1° grado

9

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa1
REPLIGEN CORPORATION

Health Technology

Aziende private7

Finance

Health Technology

Health Technology

Commercial Services

Process Industries

Finance

Finance

Vedi le connessioni aziendali
  1. Borsa valori
  2. Insiders
  3. Olivier Loeillot